Smart Inhalers Market to Reach $12.1 Billion by 2030, Driven by Poor Medication Adherence Crisis
“According to BCC Research, the global smart inhalers market is projected to grow from $5.9 billion in 2025 to $12.1 billion by 2030, at a CAGR of 15.4%, driven by increasing prevalence of asthma and COPD, growing adoption of digital health technologies and rising demand for connected respiratory care solutions.”
Boston, July 20, 2026 (GLOBE NEWSWIRE) -- The global smart inhalers market is projected to surge from $5.2 billion in 2024 to $12.1 billion by 2030, representing a compound annual growth rate of 15.4% through the forecast period, according to a new report from BCC Research titled Smart Inhalers: Global Markets. BCC Research provides objective market intelligence and strategic insights for technology-driven industries.
Key Findings
• Market expansion accelerates at 15.4% CAGR as healthcare systems grapple with medication adherence rates below 50% among asthma and COPD patients, creating urgent demand for connected monitoring solutions
• North America dominates market share, benefiting from established digital health infrastructure and recent CMS introduction of Remote Therapeutic Monitoring reimbursement codes that improve commercial viability
• Asthma prevalence drives adoption with 7.7% of the US population affected and 25 million patients requiring long-term inhaled therapies, creating substantial addressable market for digital monitoring platforms
• COPD burden intensifies market opportunity as 11.7 million US adults generate $60 billion in annual healthcare costs, with smart inhalers offering pathway to reduce expensive emergency interventions
• AI-powered analytics emerge as differentiator with machine learning capabilities for predicting exacerbations and federated learning approaches enabling privacy-preserving data analytics across patient populations
• Major pharmaceutical players lead commercialization including AstraZeneca, GSK plc, Novartis AG, and Boehringer Ingelheim International GmbH, alongside specialized digital health companies like Adherium and Amiko Digital Health Ltd.
Market Drivers
The smart inhalers market is fundamentally driven by the intersection of persistent clinical challenges and advancing digital health capabilities. Poor medication adherence remains a critical healthcare crisis, with asthma and COPD patients frequently achieving compliance rates below 50%, leading to preventable hospitalizations and emergency department visits. This adherence gap is particularly costly given COPD's $60 billion annual healthcare burden in the US alone, creating compelling economic incentives for payers and providers to invest in monitoring solutions.
The regulatory environment has become increasingly supportive, with CMS introducing Remote Therapeutic Monitoring reimbursement codes that provide clearer pathways to commercialization. Simultaneously, technological advances in Bluetooth Low Energy connectivity, sensor miniaturization, and cloud-based data transmission platforms are enabling more sophisticated monitoring capabilities while maintaining device usability for patients across age demographics.
Investment Considerations
Smart inhalers represent a compelling investment opportunity at the convergence of pharmaceutical devices and digital health, targeting established patient populations with significant unmet clinical needs. The market benefits from strong regulatory tailwinds and expanding reimbursement coverage, though investors should consider challenges including inconsistent reimbursement structures and cost sensitivity in emerging markets. Pharmaceutical giants with established inhaler portfolios appear best positioned to capture value through integrated drug-device platforms, while specialized digital health companies offer exposure to high-growth software and analytics segments. The underdiagnosis of COPD and limited commercial uptake of existing digital platforms present both risk factors and expansion opportunities for market participants.
About the Report
The report provides comprehensive market sizing, segmentation analysis, competitive intelligence, and technology forecasts for the smart inhalers market through 2030, titled Smart Inhalers: Global Markets.
About BCC Research
BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
BCC Research LLC 50 Milk St., Ste. 16, Boston, MA 02109 press@bccresearch.com | +1 781-489-7301 www.bccresearch.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
